TY - JOUR AV - public TI - Development and validation of a novel questionnaire for self-determination of the range of motion of wrist and elbow ID - heidok21636 VL - 17 UR - https://archiv.ub.uni-heidelberg.de/volltextserver/21636/ SN - 1471-2474 JF - BMC Musculoskeletal Disorders A1 - Schnetzke, Marc A1 - Schüler, Svenja A1 - Keil, Holger A1 - Aytac, Sara A1 - Studier-Fischer, Stefan A1 - Grützner, Paul-Alfred A1 - Gühring, Thorsten N2 - Background: The aim of this study was to develop and validate a novel self-administered questionnaire for assessing the patient?s own range of motion (ROM) of the wrist and the elbow. Methods: In a prospective clinical study from January 2015 to June 2015, 101 consecutive patients were evaluated with a novel, self-administered, diagram-based, wrist motion assessment score (W-MAS) and elbow motion assessment score (E-MAS). The questionnaire was statistically evaluated for test-retest reliability, patient-physician agreement, comparison with healthy population, and influence of covariates (age, gender, affected side and involvement in workers? compensation cases). Results: Assessment of patient-physician agreement demonstrated almost perfect agreement (k?>?0.80) with regard to six out of eight items. There was substantial agreement with regard to two items: elbow extension (k?=?0.76) and pronation (k?=?0.75). The assessment of the test-retest reliability revealed at least substantial agreement (k?=?0.70). The questionnaire revealed a high discriminative power when comparing the healthy population with the study group (p?=?0.007 or lower for every item). Age, gender, affected side and involvement in workers? compensation cases did not in general significantly influence the patient-physician agreement for the questionnaire. Conclusion: The W-MAS and E-MAS are valid and reliable self-administered questionnaires that provide a high level of patient-physician agreement for the assessments of wrist and elbow ROM. Level of evidence: Diagnostic study, Level II SP - 1 CY - London IS - 312 EP - 9 PB - BioMed Central Y1 - 2016/// ER -